Texas Instruments Incorporated
—- Market cap
- —
- Debt
- +$14.05B
- Cash
- −$3.23B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TXN stock price vs ORCL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Implied fair value · at TXN's multiple
Needs TXN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$20.64
Base
$24.46
Bull
$31.23
Oracle Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Intel Corporation
TXN vs INTC
QUALCOMM Incorporated
TXN vs QCOM
NVIDIA Corporation
TXN vs NVDA
Broadcom Inc.
TXN vs AVGO
Microsoft Corporation
TXN vs MSFT
Amazon.com, Inc.
TXN vs AMZN
Alphabet Inc.
TXN vs GOOGL
International Business Machines Corporation
TXN vs IBM
Cisco Systems, Inc.
TXN vs CSCO
Salesforce, Inc.
TXN vs CRM
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TXN can sustain its margin leadership and continue compounding earnings fast enough to justify a 50.6x P/E, then hold or consider only a tactical add; otherwise, the valuation gap versus ORCL and the model-implied downside argue for caution because the current price sits well above both ORCL-implied and DCF ranges.
On a relative basis, TXN is expensive versus ORCL on every major trading multiple provided, with a 50.6x P/E versus 22.3x and a 14.2x P/S versus 5.6x. The current price of $275.74 also sits above the top of the historical band ($303.31) only on the broader range context, while the model-implied P/E price is $121.41, implying -56.0% downside.
Supporting Metrics